Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade
about
EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancerCurrent status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapySecond- and third-generation ALK inhibitors for non-small cell lung cancerEfficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysisAutologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP.Clinical significance of the correlation between PLCE 1 and PRKCA in esophageal inflammation and esophageal carcinoma.HER3 over-expression and overall survival in gastrointestinal cancersMolecular alterations in the TCR signaling pathway in patients with aplastic anemia.Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAsVaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.Emerging immunotherapy for the treatment of esophageal cancer.Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cellsThe role of stromal cancer-associated fibroblasts in pancreatic cancer.Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer.Recent advances of bispecific antibodies in solid tumors.Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy.Gut microbiome modulates efficacy of immune checkpoint inhibitors.FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer.
P2860
Q26741998-4E969D92-37C1-4F30-BD7E-CC708C052F53Q26745516-FB9703A5-4CF4-4546-97D5-1409989F516CQ28072496-E0C79144-DFA0-4D0A-BFD2-9FE3FBD9B425Q28079362-58931B46-A213-401B-80B4-16C9DDFAAEECQ33429758-28C12AAC-BAB3-4FB8-8657-4E67FD0C5CE9Q33431511-DB00D6A7-912E-4A0C-A9DF-1B23DDC0CDCAQ33779451-56C18064-AB01-4F81-A8C2-94827BAF713AQ36619051-173E277D-2AE9-4419-9B18-3F2ABC9AF1ADQ36758322-22DC4818-A7C1-47DF-9AF1-D79D991AAE94Q37267862-21F68E54-CCE1-4048-B200-BBE9281B3FC1Q37741161-42273662-58A2-46E9-95F3-17419CB5FBEBQ38763851-584A87CD-B0BD-4C09-8F38-15268873A657Q38781961-919B2A11-FBA0-4769-8CF3-DADD3A15CBE7Q39205210-F1AA30C2-9C82-4C7C-A9A9-6A3235E76BC8Q39299196-E323CFAA-E64F-4E41-B0C0-36369520CD94Q41696278-28E141B5-9AA2-4CFC-A95F-7DF8938F1362Q47157402-679656AE-F995-4380-A1BB-4F1E6081B37AQ55240704-237C66A3-A180-42A7-A012-C8E5E421830EQ55347208-9532A600-247F-4885-B59D-8461F1E82FF0
P2860
Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Advances in the management of ...... of immune checkpoint blockade
@ast
Advances in the management of ...... of immune checkpoint blockade
@en
Advances in the management of ...... of immune checkpoint blockade
@nl
type
label
Advances in the management of ...... of immune checkpoint blockade
@ast
Advances in the management of ...... of immune checkpoint blockade
@en
Advances in the management of ...... of immune checkpoint blockade
@nl
prefLabel
Advances in the management of ...... of immune checkpoint blockade
@ast
Advances in the management of ...... of immune checkpoint blockade
@en
Advances in the management of ...... of immune checkpoint blockade
@nl
P2860
P3181
P1476
Advances in the management of ...... of immune checkpoint blockade
@en
P2093
Weijing Sun
P2860
P2888
P356
10.1186/S13045-015-0185-6
P407
P50
P5008
P577
2015-07-16T00:00:00Z
P5875
P6179
1028262934